insecticides (india) limited - investor presentation...productivity given land shortage and rise in...
TRANSCRIPT
Industry overview
The size of Indian agrochemicals market is expected to be around Rs 15,000 crores by 2015
Arable land stagnation Rise in MSP
Low pesticide consumption Increased institutional credit flow
Structural enablers to catalyse strong growth trajectory going forward
► Current under penetration of agrochemicals in India with pesticide consumption amongst the lowest globally
► Rising pressure to increase food productivity given land shortage and rise in population
► Rising prices of crops on the back of Minimum Support Prices (MSP)
► Use of costlier hybrid seeds
► Increasing awareness of farmers
► Labour shortage for agricultural activities on the back of NREGA
► Continued financial support from Government through subsidies and greater flow of institutional credit
105
110
115
120
125
130
135
FY
80
FY
83
FY
86
FY
89
FY
92
FY
95
FY
98
FY
01
FY
04
FY
07
FY
10
m h
ecta
res
880 980 1,030 1,110
1,080 1,100 1,120 1,285
2,000 2,300
3,000 3,200
-
700
1,400
2,100
2,800
3,500
FY09 FY10 FY11 FY12E
Rs
/ q
uin
tal
Paddy Grade A Wheat Arhar
17.0
12.0
7.0 6.6
2.5
0.4
-
3.0
6.0
9.0
12.0
15.0
18.0
Tai
wan
Japan
Kore
a
US
A
EU
India
Kg / h
ecta
re
-
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500
FY
00
FY
01
FY
02
FY
03
FY
04
FY
05
FY
06
FY
07
FY
08
FY
09
FY
10
RS
bn
Source Department of Agriculture, research reports
IIL’s goal
Help farmers to reduce input cost and better their yields
Help to bring new generation products in reach of all farmers - big,
small and marginal
Help increase awareness and lead advancement in agricultural practices
Value For Money
0
100
200
300
400
500
600
700
800
Jul-09
Sep-0
9
Nov-
09
Jan-1
0
Mar-
10
May-
10
Jul-10
Sep-1
0
Nov-
10
Jan-1
1
Mar-
11
May-
11
Jul-11
Sep-1
1
Nov-
11
Jan-1
2
Mar-
12
May-
12
Jul-12
IIL Sensex
Company overview
► Incorporated in 1996 and listed in 2007
► Large and diversified product portfolio providing complete solution for crop protection
► Over 160 products, over 100 branded formulations and over 750 SKUs
► Track record of new product launches
► Judicious mix of in-house development, brand acquisitions, technical collaboration and marketing arrangements with global players
► Wide sales and distribution network across India
► Over 230 sales representatives, over 3,000 distributors, c.50,000 retailers and 26 depots/ branches
► An ISO 9001:2000, ISO 14001 and OHSAS 18001 certified company
Large portfolio across multiple segments
23
11
8
1
65
25
20
18
88
36
28
19
0 20 40 60 80 100
Insecticides
Herbicides
Fungicides
PGRs
Institutional Branded formulations
Outperforming the index
Notes Figures have been rebased to 100
624
119
Company overview (cont.)
► State-of-the-art manufacturing facilities at Chopanki,
Udhampur, Samba and Dahej
► Established manufacturing infrastructure for
both technicals and formulations
► Recently commissioned new units with sufficient
capacity to enable sustained long term growth
► New technicals manufacturing facility and R&D
facility under construction
► Strong R&D capabilities
► R&D center recognized by DSIR and Ministry of
Science & Technology
► Accredited with NABL
► Successfully registered 27 technicals of which 15
technicals have been commercialized
► Currently in advanced stages of registration of
about 20 technical grade pesticides
Udhampur, J&K Formulations
Sambha, J&K Formulations
Dahej, Gujarat Formulations Technicals to be commissioned
Chopanki, Rajasthan Formulations and Technicals
R&D centre
Milestones
2002: Commissioning of plant at Chopanki (Rajasthan) for manufacturing wide range of innovative end-to-end agrochemicals solutions
2003: Acquired all brands of Montari Industries
2004: Commissioning of another plant at Samba (J&K)
2005: Received ISO 9001-2000 certification, R & D Lab set up at Chopanki
2006: Acquired exclusive rights to sell “Thimet “ brand in India from American Vanguard Corp, USA; Received ISO 14001-2004 certification
2007: Successfully concluded IPO; Commissioned Technical plant at Chopanki
2008: New R&D unit (at Chopanki) bagged ISO 18001:1999 certification
2009: Construction of new manufacturing facilities at Udhampur (J&K)
2010: Began construction for multi product technical plant with 10,000 TPA capacity at Dahej (Gujarat)
2011: Bagged NABL accreditation; acquired Monocil, a popular brand ; commissioned manufacturing units at Dahej and Udhampur (J&K)
2012: Launched Nuvan, Hakama and Pulsor in collaboration with AMVAC and Nissan
Management team
Finance
Pankaj Gupta CS
P.C. Pabbi Vice President
Production
Sanjeev Aggarwal GM
Rajesh Aggarwal (MD)
Information Technology
Sandeep Aggarwal CFO
H.C. Sharma DGM
H. C. Aggarwal (Chairman)
Marketing Admin & HR
K.V. Patel Unit Head
R. S. Verma Sr. Manager
M.K. Singhal GM
V.K. Garg GM
Sanjay Vats GM
Purchase
V.K. Singhal GM
Abhai Shanker GM
Anand Banka Project Head
B.P.S. Rana DGM
S.K. Choudhary Project Manager
Sanjay Vats GM
Venkat Rao GM
R&D
Dr. Mukesh DGM
Ashok Bangde GM
O.P. Karnani Unit Head
Strong brand portfolio
► IIL’s portfolio consists of several market leading brands
► Thimet, Monocil, Lethal, Victor, Indan, Sharp, Arrow, Hijack, Care, Bravo and Avone are some of IIL’s key brands
► New products launched in current year include Nuvan, Pulsor and Hakama
► Sales of top 4 brands – Thimet, Lethal, Monocil and Victor - constitutes about Rs 144 crores (26% of FY12 turnover)
► Umbrella strategy applied for new product launches via brand extensions such as Lethal Super, Victor Plus, Victor Super etc.
► Established the “Tractor Brand” of insecticides for easy recognition of all IIL products
► “Tractor Brand” has high brand equity amongst farmers and is leveraged during all new product launches
► Continued focus on branding activities, promotion through brand ambassador and other marketing initiatives
Pan-India presence
Rewari Hazipur
Bhubneshwar
Ghaziabad Hissar
Bangalore
Coimbatore
Hyderabad
Bhatinda
Howrah
Karnal
Ludhiana
Jaipur
Nagpur Raipur
Ahmedabad
Sriganganagar
Ranchi
Pune
Sindhanur
Guwahati Siliguri
Gadarpur
Indore
26 depots across 24 locations Over 230 sales personnel and over 3,100 distributors
Rajasthan
S: 8
D: 155
MP
S: 10
D: 180 Chhattisgarh
S: 5
D: 56
Jharkhand
S: 2
D: 18
Maharashtra
S: 14
D: 94
J&K
D: 18
Haryana
S: 15
D: 189
Gujarat
S: 6
D: 172
Karnataka
S: 14
D: 344
Orissa
S: 5
D: 39
Punjab
S: 36
D: 336
Bihar
S: 10
D: 44
Assam
S: 4
D: 29
Tamil Nadu
S: 14
D: 187
U.P.
S: 21
D: 203
Uttarakhand
S: 3
D: 47
AP
S: 52
D: 992
Total Sales personnel (S) : 237 Total Distributors (D) : 3,107
“Re-launch” expertise
IIL has a proven record of acquisitions of ‘high recall, but off-shelf’ brands and their successful re-launch into leading brands
► Lethal, acquired from Montari in 2002 is a shining example
► One of the most successful Brands of IIL with several brand extensions introduced
► Sales contribution of all Lethal variants in FY12 was Rs 37 crores (around 7% of turnover)
► Monocil, acquired from Nocil in 2011, is a more recent example
► One of the leading agrochemical products in India and highly accepted among the farming community
► Sales contribution in FY12 was Rs 33 crores (around 6% of turnover)
IIL has successfully partnered with several global players to market leading brands in India
► American Vanguard Corp (AMVAC)
► Thimet – Technical collaboration initiated in 2006
► Nuvan – Technical collaboration started in 2012
► Nissan Chemicals
► Hakama – New marketing collaboration started in 2012
► Pulsar - New marketing collaboration started in 2012
► Partnership arrangements with other companies such as BASF, UPL, Syngenta and Makhtesham Agan
Proven partnership experience
Increasing institutional presence
IIL is increasing its presence in the institutional segment via sales of bulk formulations and technicals
► IIL’s current portfolio includes several technicals
► Thiamethoxam, Thiophanate Methyl, Glyphosate, Metsulfuron Methyl, Butachlor, Acetamaprid, Lamda Cyhalothrin, DDVP and Bifenthrin are amongst the key technicals
► The new multi-purpose technicals manufacturing facility coming up at Dahej shall help in broadening the portfolio
► IIL’s recent investment and initiatives towards achieving greater backward integration is expected to be one of its major growth drivers going forward
Manufacturing facilities
► Chopanki (Rajasthan)
► Formulations and technicals facility
► Samba (J&K)
► Formulations facility
► Income tax exemption (100%) expected from current year upon completion of capacity expansion, for a period of 5 years
► Udhampur (J&K)
► New formulations facility commissioned in FY12
► Income tax exemption (100%) for 5 years, starting in FY2012
► Dahej (Gujarat)
► New state-of-the-art manufacturing facility; formulations commissioned in FY12 and technicals to be commissioned in the current year
► Large area sanctioned in a PCPIR (Petroleum, Chemical and Petrochemical Investment Region) zone offering significant expansion opportunity
R&D
► R&D center recognized by Ministry of Science and Technology and Department of Scientific & Industrial Research
► Facilities are NABL accredited
► New state-of-the-art R&D center in Chopanki (Rajasthan) expected to be ready in the current year
► Successfully registered 27 technicals with additional 20 technicals in advanced stages of registration
► Focus areas for R&D initiatives
► Identifying and manufacturing high value added products
► Developing complex new molecules for introduction in generics market
► Developing eco-friendly formulations
► Leveraging expertise for CRAMS
Mission of IIL’s R&D initiatives
“EVERY
BEST CAN BE BETTERED”
Farmer awareness initiatives
IIL actively organizes several farmer awareness initiatives to familiarize them with the latest developments in farming practices and new technology advancements
► Dr. Dada: Novel concept introducing techno-commercial members as the expert for all queries in the field and to help train farmers in new technologies
► Jagrukta Abhiyan: Campaigns and awareness drives organized to educate farmers about best practices and new developments
CSR initiatives
IIL is involved in a host of CSR initiatives aimed at raising farmer awareness and enable development. Some of the key activities where IIL is involved include
► Encourage the farmers for the inclusion of pulses and/or vegetables in crop rotation to increase farm income
► Promote new agricultural techniques amongst the farmers through crop seminars, farmer meeting, demonstrations and field days at farmers fields
► Provide literature for the control of various pests, such as weeds, insects and diseases, to create awareness amongst the farmers
► Educate the farmers regarding the safe and judicious use of agrochemicals
► Adopt schools and encourage girl child education
Growth trajectory of IIL
IIL has grown at approximately 33% year on year from FY2003-FY2012
We expect revenue growth to be around 45% this year and 35% in FY14, with IIL well poised to exceed Rs 1,000 crores of revenues in FY14
42 75
106 133
184 221
294
397
478
554
800
-
100
200
300
400
500
600
700
800
900
FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13E
Rs
cr
or
e
Performance across segments
Revenue split across agrochemical segments (FY12)
Revenue split across market segments (FY12)
61.5%
28.0%
6.7% 3.7%
Insecticides Herbicides Fungicides PGRs
Total = Rs 554crores
79.1%
20.9%
Branded formulations Institutional sales
Total = Rs 554crores
Going forward, we expect our institutional sales to grow at a high rate on the back of increased technicals manufacturing capacity
Diversity and focus
Revenue split across diverse regions (FY12)
Revenue split indicating strong in-house manufacturing (FY12)
Going forward, we expect to continue serving diverse geographical markets and leverage our in-house manufacturing expertise
15.7%
17.1%
10.1%
11.2%
8.3%
5.8%
31.8%
Punjab A.P. Haryana
Maharashtra UP Karnataka
Others
Domestic Branded sales = Rs 434crores
91.9%
8.1%
Manufactured in-house Traded
Total = Rs 554crores
Financials as on 31-3-2012
Summary Profit & Loss statement
Rs crores
Gross revenues 554
Net sales 522
EBITDA 56
PBT 43
PAT 33
Summary Balance Sheet
Rs crores
Net worth 182
Non current liabilities 44
Current liabilities 294
Total equity & liabilities 520
Net fixed assets (including CWIP)
143
Other non current assets 29
Current assets 349
Total assets 520
Future prospects
► Capitalize on IIL’s strengths and pursue
► Product acquisitions to compliment our product portfolio
► Marketing arrangement with global partners to enhance portfolio
► Further growth of our existing product offerings and lines
► Realize growth through commissioning of new manufacturing facilities and enhancing capacity and investing in R&D
► Build on existing market share and achieve economies of scale with manufacturing of new technicals
► Introduce new generation products
► Promote brands whose technicals is manufactured in-house
Roadmap for growth
IIL intends to leverage its expertise in successful brand launches, R&D focus and enhanced manufacturing capacity to fuel its future growth
Continued focus on establishing strong brands
Enter into manufacturing and marketing arrangements with global partners
Employ an “umbrella strategy” to introduce product extensions
Increase focus on export markets
R&D focus including in CRAMS segment
Focus on increasing number of technical registrations
Enhanced backward integration with increase in technicals manufacturing capacity
– Increase margins
– Enhance institutional sales
Significant capacity enhancement in formulations underway
Growth through R&D
► Focus on developing a strong pipeline of registrations
► IIL has over 20 technical registrations in the pipeline, several of which are in advanced stages of approval
► Increased registrations shall enable the Company to enhance its presence in the institutional business
► IIL has also invested in product registration in several other countries to diversify its geographic footprint
► New state-of-the-art R&D facility expected to be commissioned in FY13
► Continue its focus on process efficiency and cost reduction
► R&D activities to also focus on CRAMS business
Growth through Marketing
► New product introduction through tie-ups
► The Company has already launched 3 new branded formulations in the current year through tie-ups with global partners
► Nuvan: generic insecticide to be manufactured in-house under technical collaboration with AMVAC
► Pulsar: patented fungicide to be marketed in India by IIL under marketing tie up with Nissan Chemicals
► Hakama: new generation herbicide to be marketed in India by IIL under marketing tie up with Nissan Chemicals
► The Company expects to generate a turnover of around Rs 70 crores in the current year from the sales of Nuvan, Pulsar and Hakama
► New product introduction through in-house development
► IIL plans to introduce several new in-house manufactured branded formulations products and institutional products over the next two years
► IIL shall continue to leverage on its brand positioning to launch brand extensions
Growth through Manufacturing
► Manufacturing capacity expansion plan initiated in FY12 is planned to completed in FY13
► IIL plans to invest around Rs 50 crores in FY13 for completion of the expansion plan
► The Company shall set up substantial additional capacity across segments
► Key benefits of manufacturing capacity expansion
► Backward integration of several existing branded formulations leading to improvement in margins
► Enhanced capacity available for catering to institutional and exports business
Growth prospects
Year (FY)
Turnover (Rs Cr)
EBITDA (Rs Cr)
Branded Formulations Sales (Rs Cr)
Institutional Sales (Rs Cr)
2012 554 56 438 116
2013E 800 95 620
180
2014E 1,080 130
730 350
Growth prospects
► Revenue growth in FY13 will be fuelled mainly by
► Growth in established market leading brands
► New product introductions
► Enhanced institutional sales business
► The Company expects its EBITDA margin in FY13 to be in the range of 12% - 13% on the back of
► Backward integration of several branded formulations
► Some of the new product introductions would have higher margins
► Economies of scale
IIL: Success factors
► Positive industry dynamics ► Demand drivers, genetic trends, gaps in food production and burgeoning demand
► Participant in diversified markets ► Branded formulations, institutional sales & non-crop applications
► Proven product acquisition model ► Successful repositioning of acquired products and technologies
► World-class manufacturing capability ► High-quality, environmentally compliant and cost competitive
► Growth potential in international markets and institutional business ► Strong fundamentals in place
► Financial profile ► Excellent operating performance, strong financial control
IIL: Key strengths
► Growing participant in a healthy industry with significant growth potential
► Successful and adaptable business model
► Strong all India marketing network
► Diversified end-use markets - Branded & Institutional; Crop & Non-Crop
► Experience of handling leading brands in the country
► Committed and dedicated team with low attrition rate
► Strategic, efficient, cost effective and compliant manufacturing
► Organization committed to customers
► Entrepreneurial and financially prudent culture
In the coming years, we intend to assume a leadership position in the market by leveraging our strengths and capitalizing on our success factors
Disclaimer
Whereas due care and caution is taken in furnishing the information contained herein, this document has not been independently verified and IIL disclaims all responsibility and/or liability directly or indirectly on any cause of action arising out of such information. To the maximum extent permitted by law, none of IIL’s employees or agents, nor any other person accepts any liability, including, without limitation, any liability arising out of fault or negligence, for any loss arising from the use of the information contained in this presentation. No reliance should be placed on, the fairness, accuracy, completeness or correctness of this information or opinions contained herein.
Certain statements contained in this document may be statements of future expectations, forecasts and other forward-looking statements that are based on management‘s current view and assumptions. No representation or warranty, express or implied, is given as to the accuracy, completeness or correctness, likelihood of achievement or reasonableness of any forward-looking statements contained in this presentation. Such statements are by their nature subject to significant uncertainties and contingencies and the actual results, performance or events may differ materially from those expressed or implied in such statements. Readers are cautioned not to place undue reliance on any forward looking statement.